Literature DB >> 24565405

Prediction of major cardiovascular events after lung resection using a modified scoring system.

Mark K Ferguson1, Paramita Saha-Chaudhuri2, John D Mitchell3, Gonzalo Varela4, Alex Brunelli5.   

Abstract

BACKGROUND: Cardiovascular complications occur in 10% to 15% of patients after major lung resection. We evaluated the utility of a revised scoring system (thoracic revised cardiac risk index; ThRCRI) in identifying patients at increased risk for major cardiovascular complications.
METHODS: We analyzed outcomes from the Society of Thoracic Surgeons General Thoracic Database for the period 2003 to 2011 for elective major lung resection. The ThRCRI risk score was based on weighted values for serum creatinine, coronary artery disease, cerebrovascular disease, and extent of lung resection, and was stratified into the following 4 risk categories: 0 (A); 1 to 1.5 (B); 2 to 2.5 (C); and >2.5 (D). Major cardiovascular complications included myocardial infarction, adult respiratory distress syndrome, ventricular arrhythmia requiring treatment, and all-cause death.
RESULTS: A total of 26,085 patients (mean age 65.4±11.4 years; 51.3% men) underwent lobectomy (21,679; 83.2%), bilobectomy (1,446; 5.5%) or pneumonectomy (1,697; 6.5%). Major cardiovascular complications occurred in 1,125 patients (4.3%). ThRCRI scores in patients without and with major cardiovascular complications were 0.6±0.9 and 1.1±1.1 (p<0.0001). Score categories yielded incremental risks of major cardiovascular complications (A: 2.9%; B: 5.8%; C: 11.9%; D: 11.1%; p<0.0001).
CONCLUSIONS: The ThRCRI score stratified risk moderately well for major postoperative cardiovascular events after major lung resection. Use of this scoring system might help in identifying patients who would benefit from additional preoperative evaluation and from closer perioperative monitoring.
Copyright © 2014 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24565405     DOI: 10.1016/j.athoracsur.2013.12.032

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

1.  Impact of Increasing Age on Cause-Specific Mortality and Morbidity in Patients With Stage I Non-Small-Cell Lung Cancer: A Competing Risks Analysis.

Authors:  Takashi Eguchi; Sarina Bains; Ming-Ching Lee; Kay See Tan; Boris Hristov; Daniel H Buitrago; Manjit S Bains; Robert J Downey; James Huang; James M Isbell; Bernard J Park; Valerie W Rusch; David R Jones; Prasad S Adusumilli
Journal:  J Clin Oncol       Date:  2016-10-31       Impact factor: 44.544

Review 2.  Preoperative functional workup for patients with advanced lung cancer.

Authors:  Alessandro Brunelli
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

3.  Simultaneous resection of thymic and bronchial carcinoid tumors in a patient diagnosed with multiple endocrine neoplasia type 1.

Authors:  Ulaş Kumbasar; Süleyman Nahit Şendur; Yiğit Yılmaz; Tomris Erbaş; Sevgen Önder; Rıza Doğan
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2019-06-21       Impact factor: 0.332

4.  Preoperative coronary artery calcifications in veterans predict higher all-cause mortality in early-stage lung cancer: a cohort study.

Authors:  Maren E Shipe; Amelia W Maiga; Stephen A Deppen; Gretchen C Edwards; Hannah N Marmor; Rhonda Pinkerman; Gary T Smith; Elizabeth Lio; Johnny L Wright; Chirayu Shah; Jonathan C Nesbitt; Eric L Grogan
Journal:  J Thorac Dis       Date:  2021-03       Impact factor: 2.895

5.  Ventilatory efficiency is superior to peak oxygen uptake for prediction of lung resection cardiovascular complications.

Authors:  Andrej Mazur; Kristian Brat; Pavel Homolka; Zdenek Merta; Michal Svoboda; Monika Bratova; Vladimir Sramek; Lyle J Olson; Ivan Cundrle
Journal:  PLoS One       Date:  2022-08-12       Impact factor: 3.752

6.  Surgery for non-small cell lung cancer in patients with a history of cardiovascular surgery.

Authors:  Hideyuki Maeda; Masato Kanzaki; Kei Sakamoto; Tamami Isaka; Kenji Yamazaki; Takamasa Onuki
Journal:  Surg Today       Date:  2016-07-21       Impact factor: 2.549

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.